THEMA HALOZYME_THERAPEUTICS

Sie befinden sind hier: Startseite > Themen > Halozyme_Therapeutics

Thema: Halozyme Therapeutics

Halozyme Therapeutics, US40637H1095

Halozyme Therapeutics (ISIN: US40637H1095) released Q4 and full-year 2025 results showing steady operations ...

Gemini_Generated_Image_y9mufgy9mufgy9mu.png - Foto: THN

Halozyme Therapeutics stock faces pressure after Q4 earnings amid biotech volatility

ad-hoc-news.de, heute 14:41 Uhr